Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | JNCE | BIVI | ||
| Company | Akebia Therapeutics | Jounce Therapeutics Inc | Biovie Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.48 | 12.65 | 35.12 | ||
| High | 3.93 | 12.94 | 37.27 | ||
| Low | 3.46 | 11.91 | 31.18 | ||
| Last | 3.69 | 13.09 | 33.00 | ||
| Change | +0.33 | +0.54 | -1.87 | ||
| % Change | +9.82% | +4.30% | -5.36% | ||
| Volume | 10,644,086 | 501,915 | 114,598 | ||
| 20-Day Average Volume | 5,948,192 | 709,056 | 102,857 | ||
| Previous Close | 3.36 | 12.55 | 34.87 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.06 | 8.20 | 26.12 | ||
| 20-Day Raw Stochastic | 75.41% | 97.89% | 64.60% | ||
| 20-Day Relative Strength | 63.53% | 82.71% | 69.98% | ||
| Weighted Alpha | +57.35 | +66.60 | +160.78 | ||
| Today's Opinion | 8% Sell | 88% Buy | 100% Buy | ||
| Previous Opinion | 24% Sell | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 64% Sell | 8% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.02% since 01/15/21 | +38.16% since 01/15/21 | -11.42% since 01/15/21 | ||
| Low | 3.04 on 01/19/21 | 8.86 on 01/19/21 | 31.18 on 01/25/21 | ||
| High | 3.93 on 01/25/21 | 12.74 on 01/22/21 | 43.75 on 01/20/21 | ||
| 1-Month | |||||
| %Chg | +24.32% since 12/24/20 | +94.14% since 12/24/20 | +116.71% since 12/24/20 | ||
| Low | 2.71 on 12/29/20 | 6.10 on 12/29/20 | 15.05 on 12/29/20 | ||
| High | 3.93 on 01/25/21 | 12.74 on 01/22/21 | 43.75 on 01/20/21 | ||
| 3-Month | |||||
| %Chg | +14.15% since 10/23/20 | +32.77% since 10/23/20 | +272.81% since 10/23/20 | ||
| Low | 2.09 on 10/30/20 | 5.94 on 11/02/20 | 7.50 on 11/20/20 | ||
| High | 3.93 on 01/25/21 | 12.74 on 01/22/21 | 43.75 on 01/20/21 | ||
| 6-Month | |||||
| %Chg | -69.13% since 07/24/20 | +159.26% since 07/24/20 | +109.94% since 07/24/20 | ||
| Low | 2.09 on 10/30/20 | 4.43 on 08/07/20 | 7.50 on 11/20/20 | ||
| High | 12.48 on 07/28/20 | 12.74 on 01/22/21 | 43.75 on 01/20/21 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 485,651 | 500,130 | 485,251 | ||
| Shares Outstanding, K | 144,539 | 39,851 | 13,916 | ||
| Annual Sales | 335,000,000 | 147,870,000 | 0 | ||
| Annual Net Income | -279,660,000 | 56,820,000 | -16,680,000 | ||
| Last Quarter Sales | 59,990,000 | 0 | N/A | ||
| Last Quarter Net Income | -59,960,000 | -24,903,000 | 7,333,916 | ||
| 60-Month Beta | 2.11 | 1.34 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | 03/09/21 | 02/25/21 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
